← All stocks

PALISADE BIO, INC.

PALI Net buying
CIK 0001357459 #3389 in the set updated 18 Sep 2026
Bought (120 mo)
$617.29K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$420.37K
$0.00 on a plan · $303.34K straight out of an exercise
Sold at will
$117.03K
4 of 5 sales
Net
+$196.92K
+$500.26K against sales at will

By person

19 insiders · 46 transactions
0.8×

J.D. Finley holds only 0.8 times base salary in stock. $477.38K of shares against $575.00K in salary for 2025.

Salary from the company's own proxy. The shares are what J.D. Finley last reported holding, valued at $1.96, the price Common Stock was last bought or sold at on the open market here, on 9 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Baltera Robert Jr.
Director
$250.18K (6)
+$250.18K
461,904
$903.48K
Finley John David
CEO, CFO
$101.50K (12)
$310.16K (2) scheduled
−$208.66K
244,061
$477.38K
Jones Mitchell Lawrence
Chief Medical Officer
$110.02K (2)
−$110.02K
94,009
$183.88K
Daly Richard J
Chief Executive Officer
$90.00K (7)
+$90.00K
23,312
$45.60K
Trenschel Robert J.
Director
$42.30K (5)
$192.00 (1)
+$42.11K
315,399
$616.92K
LLOYD JONES JONATHAN BRIAN
Chief Financial Officer
$40.00K (2)
+$40.00K
7,859
$15.37K
Williams Donald Allen
Director
$39.47K (5)
+$39.47K
1,600,294
$3.13M
Hallam Thomas
Chief Executive Officer
$36.74K (3)
+$36.74K
57,592
$112.65K
Dawson Michael John
Chief Medical Officer
$17.09K (1)
+$17.09K
15,000
$29.34K
Wei Binxian
Director
613,355
$1.20M
+30,667,650%
Chuang Emil
Director
612,500
$1.20M
Zwick Jordan Michael
Director
336,904
$658.98K
SMITH SANDFORD D
Director
219,916
$430.16K
+2,581%
WESTREICH STANLEY
Director
143,281
$280.26K
+14.9%
OLDAKER WILLIAM CLYDE
Director
33,763
$66.04K
+123.0%
Csimma Cristina
Director
12,862
$25.16K
+20,645%
Diaz Stephanie
Director
12,800
$25.04K
Neal James R
Director
10,920
$21.36K
McRae Robert Curtis
Chief Operating Officer
625
$1.22K
+160.4%

No percentages here. This company's share count has moved by a factor of 131.1 over the window, from 1,329,516 to 174,270,558 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Finley John David
7 Jul 2026
CEO, CFO
Sold after exercise
146,798
$2.07
$303.34K

What was left out

Form 4 filings counted 153
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 4,855,018
History held since 26 Sep 2016